Remove Bioethics Remove COVID-19 Remove COVID-19 Vaccine Remove Governance
article thumbnail

How to Fairly Allocate Scarce COVID-19 Therapies

Bill of Health

Vaccines are no longer our only medical intervention for preventing severe COVID-19. The Delta variant led the federal government to resume control over mAb supply and promulgate allocation guidelines. The post How to Fairly Allocate Scarce COVID-19 Therapies appeared first on Bill of Health.

COVID-19 209
article thumbnail

Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies

Bill of Health

While receiving significant global traction and acceptance since their publication in 1985, the Siracusa Principles, the authors argue, proved to be simply “unequal to the task” of guiding States’ conduct in the context of COVID-19 because they are “unable to speak in any significant detail to the particular concerns of public health crises.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Introduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies

Bill of Health

By Roojin Habibi, Timothy Fish Hodgson, and Alicia Ely Yamin Today, as the world transitions from living in the grips of a novel coronavirus to living with an entrenched, widespread infectious disease known as COVID-19, global appreciation for the human rights implications of public health crises are once again rapidly fading from view.

article thumbnail

Do No Harm: A Call for Decarceration in Hospitals

Bill of Health

Though strict protocol typically governs everything in hospitals, for prisoners, those rules seem to go out the window, without deliberation. J was brought to the Emergency Department with a cough, but after a test, we learned he was COVID positive. Most patients with severe COVID did not present with obvious respiratory distress.

Hospitals 130
article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.

COVID-19 205
article thumbnail

Introduction to the Symposium: Health Law and Policy in an Era of Mass Suffering

Bill of Health

Last spring, the United States crossed the bleak and preventable 1,000,000-death mark for lives lost during the COVID-19 pandemic. The drawbacks associated with relying on systems of decentralized governance and federalism to address health and public health crises. By Chloe Reichel and Benjamin A.

COVID-19 130
article thumbnail

Pandemic Nihilism, Social Murder, and the Banality of Evil

Bill of Health

These daily losses matter inestimably at a human level, yet they do not matter in any meaningful way at all to the public and private institutions that govern our lives. The same nihilism led to inaction on AIDS, the workplace accidents that regularly occur in the economy, and the government’s response to the COVID pandemic.

COVID-19 364